secwatch / observer
8-K filed April 16, 2026, 7:59 PM ET ticker AUTL CIK 0001730463
other material confidence high sentiment neutral materiality 0.35

Autolus Therapeutics plc (AUTL): auditor change — Autolus Therapeutics dismisses EY UK and appoints EY US as independent auditor

Autolus Therapeutics plc

item 4.01item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Autolus Therapeutics plc engaged Ernst & Young LLP (US) as its auditor.

Action
engagement
Auditor
Ernst & Young LLP (US)
Exact text from the filing
On April 14, 2026, the Audit Committee approved the engagement of Ernst & Young LLP (US) (“EY US”) as its new independent registered public accounting firm.
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Autolus Therapeutics plc dismissed Ernst & Young LLP (UK) as its auditor.

Action
dismissal
Auditor
Ernst & Young LLP (UK)
Successor
Ernst & Young LLP (US)
Exact text from the filing
(a) Dismissal of Independent Registered Public Accounting Firm. On April 14, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of Autolus Therapeutics plc (the “Company”) dismissed Ernst & Young LLP (UK) (“EY UK”) as the Company’s independent registered public accounting firm.
View on SEC.gov

18 auditor changes filed in the last 30 days. Browse all auditor changes →

Autolus Therapeutics plc filing history →

Source: SEC EDGAR
accession 0001730463-26-000049
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.